Source:http://linkedlifedata.com/resource/pubmed/id/10802132
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-7-7
|
pubmed:abstractText |
We prolonged from 24 to 48 months a follow-up study of unipolar subjects with high recurrence rate treated with fluvoxamine (N=25) and sertraline (N=22). During the two-year additional period a significant risk of recurrences was observed during the third year of follow-up, without differences in the two long-term therapy groups. During the fourth year no patients showed new episodes of illness.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0165-0327
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
233-6
|
pubmed:dateRevised |
2009-9-28
|
pubmed:meshHeading |
pubmed-meshheading:10802132-Adult,
pubmed-meshheading:10802132-Antidepressive Agents,
pubmed-meshheading:10802132-Antidepressive Agents, Second-Generation,
pubmed-meshheading:10802132-Depressive Disorder,
pubmed-meshheading:10802132-Female,
pubmed-meshheading:10802132-Fluvoxamine,
pubmed-meshheading:10802132-Follow-Up Studies,
pubmed-meshheading:10802132-Humans,
pubmed-meshheading:10802132-Male,
pubmed-meshheading:10802132-Middle Aged,
pubmed-meshheading:10802132-Recurrence,
pubmed-meshheading:10802132-Sertraline,
pubmed-meshheading:10802132-Treatment Outcome
|
pubmed:year |
2000
|
pubmed:articleTitle |
Four-year follow-up study of sertraline and fluvoxamine in long-term treatment of unipolar subjects with high recurrence rate.
|
pubmed:affiliation |
Istituto Scientifico H. San Raffaele, Department of Neuropsychiatric Sciences, School of Medicine, University of Milan, Via Prinetti 29, 20127, Milan, Italy. centro.affettivi@hsr.it
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|